The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis
Open accessAbstract
Promoting remyelination, a major goal of an effective treatment for demyelinating diseases, has the potential to protect vulnerable axons, increase conduction velocity, and improve neurologic deficits. Strategies to promote remyelination have focused on transplanting oligodendrocytes (OLs) or recruiting endogenous myelinating cells with trophic factors. Ig-based therapies, routinely used to treat a variety of neurological and autoimmune diseases, underlie our approach to enhance remyelination. We isolated two human mAbs directed against OL surface antigens that promoted significant remyelination in a virus-mediated model of multiple sclerosis. Four additional OL-binding human mAbs did not promote remyelination. Both human mAbs were as effective as human i.v. Ig, a treatment shown to have efficacy in multiple sclerosis, and bound to the surface of human OLs suggesting a direct effect of the mAbs on the cells responsible for myelination. Alternatively, targeting human mAbs to areas of central nervous system (CNS) pathology may facilitate the opsonization of myelin debris, allowing repair to proceed. Human mAbs were isolated from the sera of individuals with a form of monoclonal gammopathy. These individuals carry a high level of monoclonal protein in their blood without detriment, lending support to the belief that administration of these mAbs as a therapy would be safe. Our results are ( i ) consistent with the hypothesis that CNS-reactive mAbs, part of the normal Ig repertoire in humans, may help repair and protect the CNS from pathogenic immune injury, and ( ii ) further challenge the premise that Abs that bind OLs are necessarily pathogenic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
Sommer, I., & Schachner, M. (1981) · Developmental Biology · doi:10.1016/0012-1606(81)90477-2 · Cited by 1,134
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
FGF modulates the PDGF-driven pathway of oligodendrocyte development
McKinnon, R. D., Matsui, T., Dubois-Dalcq, M., & Aaronsont, S. A. (1990) · Neuron · doi:10.1016/0896-6273(90)90215-2 · Cited by 597
McTigue, D. M., Horner, P. J., Stokes, B. T., & Gage, F. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05354.1998 · Cited by 592
Bögler, O., Wren, D., Barnett, S. C., Land, H., & Noble, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6368 · Cited by 578
Identification of an adult-specific glial progenitor cell
Wolswijk, G., & Noble, M. (1989) · Development · doi:10.1242/dev.105.2.387 · Cited by 485
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells
Groves, A. K., Barnett, S. C., Franklin, R. J. M., Crang, A. J., Mayer, M., Blakemore, W. F., & Noble, M. (1993) · Nature · doi:10.1038/362453a0 · Cited by 444
Remyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Fazekas, F., Deisenhammer, F., Strasser-Fuchs, S., Nahler, G., & Mamoli, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09377-4 · Cited by 381
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M., Lees, M. B., Linington, C., & Hauser, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118368 · Cited by 314
Pre-oligodendrocytes from adult human CNS
Armstrong, R., Dorn, H., Kufta, C., Friedman, E., & Dubois-Dalcq, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-04-01538.1992 · Cited by 270
Warrington, A. E., Barbarese, E., & Pfeiffer, S. E. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340102 · Cited by 261
Self-citationPersistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis
Rodriguez, M., Leibowitz, J. L., & Lampert, P. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130409 · Cited by 243
Self-citationGard, A. L., & Pfeiffer, S. E. (1989) · Development · doi:10.1242/dev.106.1.119 · Cited by 224
ELECTRON MICROSCOPIC FEATURES OF MULTIPLE SCLEROSIS LESIONS
PÉRIER, O., & GRÉGOIRE, A. (1965) · Brain · doi:10.1093/brain/88.5.937 · Cited by 203
Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin
Blakemore, W. F., Eames, R. A., Smith, K. J., & McDonald, W. I. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90179-4 · Cited by 161
Lebar, R., Lubetzki, C., Vincent, C., Lombrail, P., & Boutry, J. M. (1986) · PubMed Central · Cited by 151
Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination
Pavelko, K. D., van Engelen, B. G. M., & Rodriguez, M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02498.1998 · Cited by 146
Self-citationFranklin, R. J. M., Bayley, S. A., & Blakemore, W. F. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0025 · Cited by 146
Gumpel, M., Baumann, N., Raoul, M. M., & Jacque, C. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90449-4 · Cited by 131
Bansal, R., & Pfeiffer, S. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6181 · Cited by 121
Targeting of IgMκ Antibodies to Oligodendrocytes Promotes CNS Remyelination
Asakura, K., Miller, D. J., Pease, L. R., & Rodriguez, M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07700.1998 · Cited by 109
Self-citationNegative Regulation of Oligodendrocyte Differentiation by Galactosphingolipids
Bansal, R., Winkler, S., & Bheddah, S. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07913.1999 · Cited by 107
Miller, D. J., Sanborn, K. S., Katzmann, J., & Rodriguez, M. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06230.1994 · Cited by 102
Self-citationHurez, V. J., Kazatchkine, M. D., Vassilev, T. L., Ramanathan, S., Pashov, A. D., Basuyaux, B., de Kozak, Y., Bellon, B., & Kaveri, S. V. (1997) · Blood · doi:10.1182/blood.v90.10.4004 · Cited by 101
Self-citationJeffery, N. D., Crang, A. J., O'Leary, M. T., Hodge, S. J., & Blakemore, W. F. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00564.x · Cited by 91
O'Leary, M. T., & Blakemore, W. F. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970415)48:2<159::aid-jnr8>3.0.co;2-b · Cited by 91
McGavern, D. B., Murray, P. D., & Rodriguez, M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<492::aid-jnr3>3.0.co;2-p · Cited by 83
Self-citationAsakura, K., Miller, D. J., Murray, K., Bansal, R., Pfeiffer, S. E., & Rodriguez, M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960201)43:3<273::aid-jnr2>3.0.co;2-g · Cited by 77
Self-citationMechanisms of High-Dose Intravenous Immunoglobulins in Demyelinating Diseases
Stangel, M., Toyka, K. V., & Gold, R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.661 · Cited by 70
Njenga, M. K., Pavelko, K. D., Baisch, J., Lin, X., David, C. S., Leibowitz, J. L., & Rodriguez, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1729-1737.1996 · Cited by 67
Self-citationO‐2A glial progenitors from mature brain respond to CNS neuronal cell line‐derived growth factors
Hunter, S. F., & Bottenstein, J. E. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280415 · Cited by 57
Asakura, K., Hunter, S. F., & Rodriguez, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062281.x · Cited by 49
Self-citationOligodendrocyte Development in Culture Systems
Pfeiffer, S. E. (1984) · Springer eBooks · doi:10.1007/978-1-4757-6066-8_7 · Cited by 49
Miller, D. J., Bright, J. J., Sriram, S., & Rodriguez, M. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00027-1 · Cited by 48
Self-citationStangel, M., Compston, A., & Scolding, N. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00035-1 · Cited by 31
Noseworthy, J. H., O’Brien, P. C., van Engelen, B. G. M., & Rodriguez, M. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.suppl.11 · Cited by 31
Self-citationMiller, D. J., Asakura, K., & Rodriguez, M. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410302 · Cited by 19
Self-citationRegenerative potential of adult O1+ oligodendrocytes
Rosano, C., Felipe-Cuervo, E., & Wood, P. M. (1999) · Glia · doi:10.1002/(sici)1098-1136(199909)27:3<189::aid-glia1>3.0.co;2-i · Cited by 15
Drescher, K. M., Rivera-Quiñones, C., Lucchinetti, C. F., & Rodriguez, M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00095-2 · Cited by 13
Self-citationCohen, J. A., Williams, W. V., Geller, H. M., & Greene, M. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1266 · Cited by 13
(1997) · doi:10.1002/(sici)1097-4547(19971015)50:2<215::aid-jnr10>3.0.co;2-7
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
Self-citationWhy does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn917 · Cited by 837
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
Weiner, H. L. (2009) · Annals of Neurology · doi:10.1002/ana.21640 · Cited by 344
Metadata
- Authors
- Warrington, A. E., Asakura, K., Bieber, A. J., Ciric, B., Van Keulen, V., Kaveri, S. V., Kyle, R. A., Pease, L. R., & Rodriguez, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-06-06
- Volume
- 97
- Issue
- 12
- Pages
- 6820-6825
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1998253454
- Cited by
- 254
- References
- 45
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.